Disease status is better characterized by BCR-ABL/BCR transcript ratio than by BCR-ABL transcript level in patients with CML.

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023736%3A_____%2F02%3A00000021" target="_blank" >RIV/00023736:_____/02:00000021 - isvavai.cz</a>

Result on the web

—

DOI - Digital Object Identifier

—

Result language

angličtina

Original language name

Disease status is better characterized by BCR-ABL/BCR transcript ratio than by BCR-ABL transcript level in patients with CML.

Original language description

In some CML patients without cytogenetic response to treatment the BCR-ABL/BCR transcript ratio better characterizes disease status and disease prognosis than the BCR-ABL transcript concentration. The results suggest a role of BCR gene in CML development.

Czech name

—

Czech description

—

Type

J_x - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

CEP classification

FD - Oncology and haematology

OECD FORD branch

—

Project

<a href="/en/project/NC5902" target="_blank" >NC5902: Molecular markers of chronic myeloid leukemia progression to blast crisis.</a><br>

Continuities

P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Publication year

2002

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Name of the periodical

The hematology journal

ISSN

1466-4860

e-ISSN

—

Volume of the periodical

3

Issue of the periodical within the volume

S1

Country of publishing house

GB - UNITED KINGDOM

Number of pages

1

Pages from-to

287

UT code for WoS article

—

EID of the result in the Scopus database

—